Cogent Biosciences (COGT) EPS (Basic) (2017 - 2026)
Cogent Biosciences (COGT) posted quarterly EPS (Basic) of -$0.69 for Q1 2026, down 7.92% year-over-year from -$0.74 in Q1 2025, and up 19.7% quarter-over-quarter from -$0.85 in Q4 2025.
Powered by 
Analysis
Cogent Biosciences (COGT) EPS (Basic) (2017 - 2026) Analysis & Trends
Cogent Biosciences (COGT) has reported EPS (Basic) for 10 consecutive years, with -$0.69 the latest figure, recorded in Q1 2026.
- In Q1 2026, EPS (Basic) fell 7.92% year-over-year to -$0.69; the TTM figure through Mar 2026 stood at -$2.36 (up 1.39% YoY), while the FY2025 annual figure was -$8.38, down 82.76% from the prior year.
- EPS (Basic) climbed to -$0.69 in Q1 2026 per COGT's latest filing, from -$0.85 in the prior quarter.
- Across five years, EPS (Basic) topped out at -$0.58 in Q4 2024 and bottomed at -$1.51 in Q2 2022.
- Historically, EPS (Basic) has averaged -$0.73 across 5 years, with a median of -$0.67 in 2024.
- Annual changes were most pronounced in 2022 — EPS (Basic) tumbled 167.23% — and 2023, when it jumped 58.12%.
- Cogent Biosciences' EPS (Basic) stood at -$0.68 in 2022, then decreased by 8.8% to -$0.74 in 2023, then increased by 22.05% to -$0.58 in 2024, then slumped by 47.9% to -$0.85 in 2025, then climbed by 19.7% to -$0.69 in 2026.
- Business Quant data shows COGT's EPS (Basic) at -$0.69 in Q1 2026, -$0.85 in Q4 2025, and -$0.62 in Q3 2025.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EPS (Basic) (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.27 Bn | 131.42 Bn | 2.84 Bn | 4.34 |
| 2 | Regeneron Pharmaceuticals | 85.55 Bn | 77.56 Bn | 3.93 Bn | 12.62 |
| 3 | Argenx Se | 63.45 Bn | 58.27 Bn | 1.37 Bn | 7.70 |
| 4 | Moderna | 57.73 Bn | 52.59 Bn | 52.00 Mn | -1.96 |
| 5 | Revolution Medicines | 44.08 Bn | 44.08 Bn | - | -3.06 |
| 6 | BeOne Medicines | 39.95 Bn | 34.85 Bn | 1.53 Bn | 2.12 |
| 7 | Alnylam Pharmaceuticals | 35.14 Bn | 31.84 Bn | 992.69 Mn | 1.23 |
| 8 | Royalty Pharma | 28.44 Bn | 27.60 Bn | - | 0.18 |
| 9 | Insmed | 27.32 Bn | 26.16 Bn | 358.27 Mn | -0.06 |
| 10 | Cogent Biosciences | 5.93 Bn | 5.93 Bn | - | -0.56 |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | -0.56 |
| Mar 31, 2026 | -0.60 |
| Dec 31, 2025 | -0.74 |
| Sep 30, 2025 | -0.59 |
| Jun 30, 2025 | -0.64 |
| Mar 31, 2025 | -0.63 |
| Dec 31, 2024 | -0.67 |
| Sep 30, 2024 | -0.64 |
| Jun 30, 2024 | -0.59 |
| Mar 31, 2024 | -0.61 |
| Dec 31, 2023 | -0.68 |
| Sep 30, 2023 | -0.64 |
| Jun 30, 2023 | -0.59 |
| Mar 31, 2023 | -0.58 |
| Dec 31, 2022 | -0.71 |
| Sep 30, 2022 | -0.51 |
| Jun 30, 2022 | -0.72 |
| Mar 31, 2022 | -0.69 |
| Dec 31, 2021 | -0.66 |
| Sep 30, 2021 | -0.49 |